Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
Copyright 2024 – Finance News Network
Source: Finance News Network
27 Feb 2020 - NetLinkz Limited (ASX:NET) Executive Chairman and CEO, James Tsiolis talks about the significance of the company's agreement to provides its Virtual Secure Network to a World Bank-sponsored initiative to improve water sanitation services in selected areas of the Deyang Municipality of Sichuan Province.
Read More14 Dec 2022 - RareX Limited (ASX:REE) Managing Director Jeremy Robinson discusses progress at the Cummins Range rare earths project and a potential resource upgrade.
Read More16 Oct 2023 - Damon Dorman, the Managing Director at Golden Mile Resources (ASX:G88), discusses the discovery of vermiculite in their Quicksilver Nickel project in Western Australia.
Read More13 May 2025 - Cameron Cormack, Senior Portfolio Manager at VanEck, on ETF strategy and market outlook
Read More15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's synthetic antibiotic RECCE 327, commencement of Phase I human clinical trial in 2H20 and key priorities.
Read More19 Mar 2024 - Torque Metals Limited (ASX:TOR) Managing Director Cristian Moreno discusses the roadmap for the company and promising recent results.
Read More08 Sep 2021 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses FY21 results and the outlook for FY22.
Read More26 Mar 2025 - The pros and cons of lithium and CERENERGY grid storage batteries
Read More12 Jul 2023 - Regan Saveall, CEO of leading UK CBD company Dragonfly Biosciences, discusses the company and its plans to list on the ASX in August.
Read More28 Feb 2020 - Washington H. Soul Pattinson and Company Limited (ASX:SOL) Managing Director, Todd Barlow provides a portfolio update and talks about the approach to investment that has enabled the company to outperform over decades.
Read More
